Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
2ÁÖ ¹Ý Àü ³»½Ã°æ¿¡¼ pyloric mass°¡ ¹ß°ßµÇ¾úÀ¸³ª Á¶Á÷°Ë»ç¿¡¼ ¾ÏÀ¸·Î ³ª¿ÀÁö ¾Ê¾Æ Å« º´¿øÀ» ±ÇÀ¯¹Þ¾Æ ÀÇ·ÚµÈ ºÐÀÔ´Ï´Ù.
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
Borrmann type IV Áß¿¡¼ antrum¿¡ ±¹ÇÑµÈ °æ¿ì´Â ³»½Ã°æ Áø´ÜÀÌ ½±Áö ¾Ê½À´Ï´Ù. ÀÇ·Ú ÈÄ ´Ù½Ã ½ÃÇàÇÑ ³»½Ã°æ°Ë»ç¿¡¼ antral typeÀÇ B-IV·Î Áø´ÜµÇ¾ú½À´Ï´Ù. ÀÌ È¯Àڴ ù ³»½Ã°æ °Ë»ç¿¡¼ pyloric mass°¡ ÀǽɵǾú±â ¸ÁÁ¤ÀÌÁö ¾î¶² ȯÀÚ´Â ¾Æ¿¹ mass°¡ ÀǽɵÇÁö ¾Ê¾Ò´ø °æ¿ìµµ ÀÖ½À´Ï´Ù.
Distal antrumÀÌ ´Ù¼Ò edematousÇØ º¸ÀÌ°í pyloric ringÀÌ ¾ÆÁÖ ¾à°£ Á¼¾ÆÁö´Â Á¤µµÀÇ ¼Ò°ß¸¸ º¸¿´´ø ¿¹µµ ÀÖ½À´Ï´Ù. Antral typeÀÇ Borrmann type IV´Â ÀÌ·¯ÇÑ º´ÀÌ ÀÖ´Ù´Â disease entity¸¦ ¾Æ´Â »ç¶÷¸¸ Áø´ÜÇÒ ¼ö ÀÖ´Â ±×·± º´ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º´ÀÇ Á¸À縦 ¸ð¸£°í ÀÖ´Ù°¡ ³»½Ã°æÀ» ÅëÇÏ¿© Áø´ÜÇÏÁö ¸øÇÏ°í Ä¡·á°¡ Áö¿¬µÇ´Â ¼ö°¡ ÀÖ½À´Ï´Ù. üÁß°¨¼Ò³ª ±¸Åä µîÀ» º¸ÀΠȯÀÚ¿¡¼ ÀûÀýÇÑ ±Ý½ÄÀ» ÇÏ¿´À½¿¡µµ ºÒ±¸ÇÏ°í À§³»¿¡ ´Ù·®ÀÇ À½½ÄÀÌ ³²¾ÆÀÖ´Â ¿¹¿¡¼ ´õ¿í ÀǽÉÀ» ÇØ¾ß ÇÕ´Ï´Ù.
ÀÌ È¯ÀÚ¿¡¼´Â Áø´ÜÀÌ ¹Ù·Î µÇ¾ú±â ¸ÁÁ¤ÀÌÁö (À§Ã¼ºÎ¸¦ ÁַΠħ¹üÇÏ´Â ÈçÇÑ ÇüÅÂÀÇ Borrmann type IV¿Í ¸¶Âù°¡Áö·Î) medico-legal problemÀ¸·Î ¿¬°áµÇ±â ½¬¿î »óȲÀ̾ú½À´Ï´Ù. ¸ðµÎ ÁÖÀÇÇØ¾ß ÇÏ°Ú½À´Ï´Ù. ¼ö¼ú ÈÄ ÃÖÁ¾ º´¸®¿¡¼ stage°¡ ¸Å¿ì ÁÁÁö ¾Ê¾Ò½À´Ï´Ù.
- Depth of invasion : direct extension to adjacent structure (pT4)
- Resection margin: free from carcinoma
- Lymph node metastasis : metastasis to 4 out of 60 regional lymph nodes (pN1)
(12a, 2/9; 14v, 1/2; perigastric, 1/6)
- Lymphatic invasion : present
- Perineural invasion : present
- Associated findings : mesenteric seeding
2014. 6. 10. ÀÌÁØÇà